Efficacy and safety of a fixed combination of insulin degludec/insulin aspart in children and adolescents with type 1 diabetes: A randomized trial

Journal

Pediatric Diabetes

Date Issued

2018

Author(s)

Battelino, Tadej

Deeb, Larry C

Ekelund, Magnus

Kinduryte, Ona

Klingensmith, Georgeanna J

Kovarenko, Margarita

Shehadeh, Naim

DOI

10.1111/pedi.12724

Abstract

Insulin degludec/insulin aspart (IDegAsp) is a fixed soluble co-formulation of basal and bolus insulin.